Posts With Tag Entrada Therapeutics

Showing 1 - 2 of 2 Posts

Entrada Therapeutics, Inc. 8-K Report: Key Shareholder Updates on February 24, 2025

•

Form 8-K

•

2025-02-24

Last updated: 2 months ago

Entrada Therapeutics, Inc. 8-K Report: Key Shareholder Updates on February 24, 2025

Discover essential insights from Entrada Therapeutics' 8-K filing on significant events affecting shareholders. Stay informed about TRDA stock developments and company actions.

Entrada Therapeutics NASDAQ 8-K Filing Biotechnology Public Company Reporting

Entrada Therapeutics 8-K Report: Key Insights & Filing Date January 15, 2025

•

Form 8-K

•

2025-01-15

Last updated: 4 months ago

Entrada Therapeutics 8-K Report: Key Insights & Filing Date January 15, 2025

Explore the latest 8-K filing by Entrada Therapeutics, Inc. on January 15, 2025, detailing company info, stock data, and regulatory compliance.

Entrada Therapeutics biotechnology NASDAQ TRDA financial reporting XBRL compliance